Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Literature DB >> 16973541

Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Melanie A Samuel¹, Michael S Diamond.

Abstract

Entities: Disease Gene

Mesh：

Year: 2006 PMID： 16973541 PMCID： PMC1617273 DOI： 10.1128/JVI.01122-06

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

× No keyword cloud information.

202 in total

Review 1. The role of IFN-gamma in immune responses to viral infections of the central nervous system.

Authors: David A Chesler; Carol Shoshkes Reiss
Journal: Cytokine Growth Factor Rev Date: 2002-12 Impact factor: 7.638

2. West Nile virus-induced bax-dependent apoptosis.

Authors: M C Parquet; A Kumatori; F Hasebe; K Morita; A Igarashi
Journal: FEBS Lett Date: 2001-06-29 Impact factor: 4.124

3. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH.

Authors: S L Allison; J Schalich; K Stiasny; C W Mandl; C Kunz; F X Heinz
Journal: J Virol Date: 1995-02 Impact factor: 5.103

4. Variation in virulence of West Nile virus strains for house sparrows (Passer domesticus).

Authors: Stanley A Langevin; Aaron C Brault; Nicholas A Panella; Richard A Bowen; Nicholas Komar
Journal: Am J Trop Med Hyg Date: 2005-01 Impact factor: 2.345

5. ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy.

Authors: Juan Arroyo; Chuck Miller; John Catalan; Gwendolyn A Myers; Marion S Ratterree; Dennis W Trent; Thomas P Monath
Journal: J Virol Date: 2004-11 Impact factor: 5.103

6. A recombinant envelope protein vaccine against West Nile virus.

Authors: Michel Ledizet; Kalipada Kar; Harald G Foellmer; Tian Wang; Sandra L Bushmich; John F Anderson; Erol Fikrig; Raymond A Koski
Journal: Vaccine Date: 2005-04-06 Impact factor: 3.641

Review 7. West Nile virus: where are we now?

Authors: Bruno P Granwehr; Kristy M Lillibridge; Stephen Higgs; Peter W Mason; Judith F Aronson; Gerald A Campbell; Alan D T Barrett
Journal: Lancet Infect Dis Date: 2004-09 Impact factor: 25.071

Review 8. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features.

Authors: B K Kleinschmidt-DeMasters; Brad A Marder; Marilyn E Levi; Stephen P Laird; J Trevor McNutt; Edward J Escott; Gregory T Everson; Kenneth L Tyler
Journal: Arch Neurol Date: 2004-08

9. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Authors: Michael S Diamond; Bimmi Shrestha; Anantha Marri; Darby Mahan; Michael Engle
Journal: J Virol Date: 2003-02 Impact factor: 5.103

10. Experimental infection of North American birds with the New York 1999 strain of West Nile virus.

Authors: Nicholas Komar; Stanley Langevin; Steven Hinten; Nicole Nemeth; Eric Edwards; Danielle Hettler; Brent Davis; Richard Bowen; Michel Bunning
Journal: Emerg Infect Dis Date: 2003-03 Impact factor: 6.883

162 in total

1. Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults.

Authors: Rex Biedenbender; Joan Bevilacqua; Anne M Gregg; Mike Watson; Gustavo Dayan
Journal: J Infect Dis Date: 2011-01-01 Impact factor: 5.226

10. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.

Authors: Stephane Daffis; Melanie A Samuel; Mehul S Suthar; Brian C Keller; Michael Gale; Michael S Diamond
Journal: J Virol Date: 2008-06-18 Impact factor: 5.103

Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Review 1. The role of IFN-gamma in immune responses to viral infections of the central nervous system.

2. West Nile virus-induced bax-dependent apoptosis.

3. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH.

4. Variation in virulence of West Nile virus strains for house sparrows (Passer domesticus).

5. ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy.

6. A recombinant envelope protein vaccine against West Nile virus.

Review 7. West Nile virus: where are we now?

Review 8. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features.

9. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

10. Experimental infection of North American birds with the New York 1999 strain of West Nile virus.

1. Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults.

2. Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses.

Review 3. Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Review 4. Forward genetic dissection of innate response to infection in inbred mouse strains: selected success stories.

5. Flavivirus nonstructural protein NS1: complementary surprises.

6. Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis.

7. Identification of novel small-molecule inhibitors of West Nile virus infection.

Review 8. West Nile virus infection and immunity.

Review 9. Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved.

10. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.